Cargando…
Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study
BACKGROUND: To evaluate the association between the therapeutic outcomes of sorafenib for advanced hepatocellular carcinoma (HCC) and the parameters of intravoxel incoherent motion (IVIM). METHODS: Nine patients were evaluated prospectively. All patients were Child-Pugh score A. The mean dimension o...
Autores principales: | Shirota, Natsuhiko, Saito, Kazuhiro, Sugimoto, Katsutoshi, Takara, Kenichi, Moriyasu, Fuminori, Tokuuye, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731920/ https://www.ncbi.nlm.nih.gov/pubmed/26822946 http://dx.doi.org/10.1186/s40644-016-0059-3 |
Ejemplares similares
-
DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study
por: Saito, Kazuhiro, et al.
Publicado: (2018) -
Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases()
por: Paschoal, André M., et al.
Publicado: (2018) -
Optimal Model Mapping for Intravoxel Incoherent Motion MRI
por: Liao, Yen-Peng, et al.
Publicado: (2021) -
Intravoxel incoherent motion (IVIM) and non-Gaussian diffusion MRI of the lactating breast
por: Iima, Mami, et al.
Publicado: (2018) -
Variability of non-Gaussian diffusion MRI and intravoxel incoherent motion (IVIM) measurements in the breast
por: Iima, Mami, et al.
Publicado: (2018)